UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
and Exchange Act of 1934
Date of Report (Date of earliest event reported):
June 9, 2015
PRAXSYN CORPORATION
(Exact name of Registrant as specified in its
charter)
Nevada |
|
333-130446 |
|
20-3191557 |
(State
or other jurisdiction
of incorporation) |
|
(Commission
File Number) |
|
(IRS
Employer
Identification No.) |
|
|
|
|
|
18013
Sky Park Circle, Suite A, Irvine, CA 92614 |
(Address
of principal executive offices, including zip code) |
|
(949)
777-6112 |
(Registrant’s
telephone number, including area code) |
Check the appropriate box below if the Form
8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
[ ] Written communication pursuant
to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).
Item 1.01 Entry into a Material
Definitive Agreement
On June 9, 2015 Mesa Pharmacy, Inc. (“Mesa”),
a wholly subsidiary of Praxsyn Corporation, a Nevada corporation (the “Company”) entered into a Services Agreement
(“Agreement”) as attached hereto and incorporated by this reference herein as Exhibit 10.1 with NHS Pharma
Sales, Inc., a California corporation (“NHS”). Below is a summary of the “Services” to be performed by
NHS pursuant to the Agreement:
| ● | Insurance
contract reviews and negotiations; |
| ● | Due
diligence for mergers and acquisitions; |
| ● | Advice
and assistance with desk and on-sight insurance audits; |
| ● | Marketing
and the promotion of Mesa’s products and services. |
The material terms of the Agreement include
that: a) the term of the Agreement shall be for one year; b) either party may terminate the Agreement without cause upon giving
the other party thirty (30) days’ written notice; c) in line with the previous compensation paid to NHS by Mesa, Mesa shall
pay NHS monthly scheduled flat fee payments totaling $120,000,000 over the term of the Agreement for the Services; and d) the
Script Processing Services Contract, dated December 4, 2014 and the Marketing Company Agreement, dated January 26, 2015, entered
into by Mesa and NHS are now null and void and of no further effect.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
10.1 |
Services
Agreement, dated June 9, 2015 |
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
|
By: |
/s/
Edward Kurtz |
|
|
Edward
Kurtz, Chief Executive Officer |
Dated: June 15, 2015
Services
Agreement
This
SERVICES AGREEMENT, is entered into as of June 9, 2015 (the “Effective Date”), by and between NHS
PHARMA SALES INC., a corporation organized and existing under the laws of the State of California (hereinafter referred to
as “NHS” or the “Company”) whose legal address is 495 La Tortuga Dr., #120, Vista, CA 92081,
and MESA PHARMACY, INC. a corporation organized and existing under the laws of the state of California, (hereinafter referred
to as MESA) whose legal address is 18013 Sky Park Circle, Suite D Irvine, CA 92614.
WHEREAS,
the parties hereto entered into a Script Processing Service Contract dated December 4, 2014 and a Marketing Company Agreement
dated January 26, 2015 (collectively, the “Previous Contracts”);
WHEREAS,
the parties hereto agree to cancel, and make null and void the Previous Contracts by entering into this Agreement;
WHEREAS,
pursuant to this Agreement, NHS will provide certain pharmacy consulting services to MESA including but not
limited to billing services, insurance contract reviews and negotiations, due diligence for mergers and acquisitions, advice and
assistance with desk and on-sight insurance audits, marketing, and the promotion of MESA’s products and services
in the geographical areas where MESA has viable pharmacy licenses (collectively, the “Services”), upon
the terms and conditions hereinafter set forth.
NOW,
THEREFORE, for good and valuable consideration, the receipt of which is hereby acknowledged, the parties hereto mutually agrees
to the following:
1.
TERRITORY:
The
territory in which NHS is conducting the Services will consist of the United States of America.
2.
DUTIES OF NHS
The
Services to be provided herein by NHS shall be provided in a professional manner, consistent with prevailing industry standards
for such Services. NHS shall devote such time and effort to providing the Services as is reasonably necessary to comply
with the terms of this Agreement; provided that NHS shall determine the time allocated to providing the Services and the
manner in which the Services are provided. NHS will at all times emphasize and adhere to all regulations and practices,
and shall at all times conduct the Services in a professional manner.
3.
AGENCY
MESA
shall engage NHS as an independent contractor in providing the Services as described herein, and under no circumstances
will NHS purport to legally bind MESA in any matter, or hold itself out as an agent with legal authority to bind
MESA without MESA’S prior written consent.
4.
RULES OF CONDUCT
NHS
shall adhere to the following rules of conduct, which include, but are not limited to:
(a)
NHS, shall not disparage, denigrate, “run down” or make any negative comments regarding another manufacturer
or competitors’ products or services.
Page | 1
Services
Agreement
(b)
NHS shall not solicit or sell MESA products and/or accessories, or enter into a type of arrangement, wherein the
sale of MESA products is made conditional in any way on a user’s purchase of another company’s products.
(c)
NHS shall at all times maintain a professional appearance and shall not perform any of his duties set forth in this Agreement,
while intoxicated in any manner or under the influence of any illegal drug.
(d)
NHS shall comply with all applicable laws while performing the Services. The parties will execute a Business Associate Addendum,
to address any protected health information to which NHS, and the NHS Groups, may require access to perform its duties
under this Agreement.
(e)
Under no circumstances shall the NHS, and/or the NHS Groups market, sell or demonstrate MESA products and accessories
together with any after-market product that has not been approved by MESA.
(f)
NHS understands and agrees that any failure to enforce the paragraphs contained in section 5 of this Agreement is not to
be considered a waiver of MESA’s rights hereunder and NHS, and each NHS representative, and NHS Group,
hereby waives any right to the defense of waiver.
Any
violation of any of the above provisions shall be grounds for immediate termination of this Agreement by MESA.
5.
PERSONNEL
NHS
shall not use any person to perform any duties under this Agreement, unless said person has completed all the following:
(a)
Successfully passed the MESA Presentation and Product Training Course, and any other tests or courses deemed necessary to
perform the duties as provided herein.
(b)
Received MESA’s prior approval.
If
any person employed by, or affiliated with NHS performs any duties not approved by MESA, NHS shall waive its
right to receive commissions and MESA shall have the right to immediately terminate this Agreement. NHS agrees and
understands that MESA may, at any time, request that a member of NHS, and/or any of the NHS Groups, take and
successfully complete educational courses in order to perform the Services.
6.
USE OF INFORMATION
Only
approved information, and terms and conditions by MESA will be used in any advertising, sales promotions, solicitation and
other duties set forth in this Agreement. NHS will not undertake to design or re-engineer MESA products and/or accessories,
or advise any person on any technical specification, training practices, bulletins, or accepted practices of MESA.
IN
THE EVENT NHS ADVISES ANY PERSON CONTRARY TO MESA POLICIES, SPECIFICATIONS, TERMS AND CONDITIONS OR PROCEDURES CONCERNING MESA’S
PRODUCT LINE, OR THE PROPER USE OF MESA’S PRODUCTS, OR INDUCES ANY PERSON TO USE OR APPLY MESA’S PRODUCTS BY MISREPRESENTATION
OF THE PRODUCT, ITS CHARACTERISTICS, USE, COST, AVAILABILITY, SAFETY OR APPLICATIONS, NHS SHALL INDEMNIFY, DEFEND, PAY, SAVE AND
HOLD MESA HARMLESS FROM ANY AND ALL CLAIMS, COSTS, JUDGEMENTS, AND DAMAGES, INCLUDING REASONABLE ATTORNEY’S FEES AND EXPENSES OF
COUNSEL, WHICH ARE INCURRED AS A DIRECT OR INDIRECT CONSEQUENCE THEREOF.
Page | 2
Services
Agreement
7.
FLAT FEE FOR SERVICES
Subject
to the terms and conditions of this Agreement, NHS will receive a flat fee for the Services in accordance with the following
schedule:
(a)
NHS will receive a flat fee for the Services performed hereunder. The flat fee shall
be paid via wire transfer or check in accordance with the following schedule:
10-Jun-15 |
$1,000,000 |
20-Jun-15 |
$2,000,000 |
5-Jul-15 |
$2,250,000 |
20-Jul-15 |
$2,500,000 |
5-Aug-15 |
$2,750,000 |
20-Aug-15 |
$3,000,000 |
5-Sep-15 |
$3,500,000 |
20-Sep-15 |
$3,750,000 |
5-Oct-15 |
$4,500,000 |
20-Oct-15 |
$5,000,000 |
5-Nov-15 |
$5,500,000 |
20-Nov-15 |
$6,250,000 |
5-Dec-15 |
$6,500,000 |
20-Dec-15 |
$6,500,000 |
5-Jan-16 |
$6,500,000 |
20-Jan-16 |
$6,500,000 |
5-Feb-16 |
$6,500,000 |
20-Feb-16 |
$6,500,000 |
5-Mar-16 |
$6,500,000 |
20-Mar-16 |
$6,500,000 |
5-Apr-16 |
$6,500,000 |
20-Apr-16 |
$6,500,000 |
5-May-16 |
$6,500,000 |
20-May-16 |
$6,500,000 |
Total= |
$120,000,000 |
Page | 3
Services
Agreement
(b) The
parties intend that the flat fee due under this Agreement shall be consistent with applicable laws. The compensation
set forth herein is based on an agreement of the parties as to the fair market value for the Services. The parties have made
such investigation as is necessary to satisfy themselves as to the appropriateness of the levels of compensation. To the
extent that any change in law, regulation or judicial interpretation of applicable law would render any element of
compensation hereunder to be illegal, upon the request of either party, the parties shall confer promptly to negotiate an
adjustment to the relevant element of compensation or modification of the Services to conform to the law
(c) NHS,
shall be responsible for the payment of all expenses that it incurs in the provision of the Services and all taxes, whether based
on income, payroll or otherwise, that may be imposed on the commissions paid hereunder. MESA shall have no obligation to
reimburse or pay any expenses on behalf of NHS, and/or the NHS Groups, unless approved by MESA prior to such
expenditure.
8.
TRADE SHOWS AND CONVENTIONS
NHS
may from time to time attend national trade shows, meetings or training programs if requested or authorized by MESA.
9.
TECHNICAL SUPPORT AND INSURANCE
NHS
shall provide technical and training support and insurance as needed.
10.
SUBCONTRACTING OR ASSIGNMENT
It
is agreed that subcontracting or assignment of this Agreement may happen only by the mutual written consent of the parties. Under
no circumstances will NHS subcontract, assign, delegate or otherwise have any person or entity perform any of the duties
and obligations of NHS under this Agreement without MESA’s express written consent.
11.
GOVERNING LAW AND DISPUTES
This
Agreement shall be deemed to have been made in California and shall be governed and construed in accordance with the laws of the
State of California.
Should
a disagreement arise over any of the provisions relating to this Agreement, NHS and MESA shall first meet to make
a good faith effort to settle any dispute. If this meeting is unsuccessful, both parties hereby agree that any unresolved dispute
shall be settled by arbitration under the applicable rules of the American Arbitration Association, and both parties agree to be
bound by the decision of the arbitrator and to pay their proportionate fees as required under the rules. Judgment upon the award
rendered by the arbitrator(s) may be entered into any court having jurisdiction thereof.
12.
TERM
This Agreement shall be effective as of the
Effective Date, and the term of this Agreement shall be for one year (the “Term”), terminating on June 5, 2016 (“Termination
Date”).
Page | 4
Services
Agreement
13.
TERMINATION
Except
as otherwise specified herein:
(a) Termination for Cause by Either Party. Except as provided in Sections (b) and (c)
below, either party may terminate this Agreement for cause upon written notice to the other party specifying the nature of the
alleged breach of this Agreement. For purposes of this Agreement, “cause” shall be construed to mean a material breach
of an obligation to be performed hereunder, that is not cured within thirty (30) days or for which reasonable steps to cure are
not undertaken and diligently and continuously pursued if such cure cannot reasonably be achieved during such thirty (30) day
period.
(b) Bankruptcy.
Either party may terminate this Agreement effective immediately upon written notice, if the other party files a petition in
bankruptcy, is adjudicated bankrupt, or takes advantage of the insolvency laws of any jurisdiction, makes an assignment for
the benefit of creditors, is voluntarily or involuntarily dissolved, or has a receiver, trustee, or other court officer
appointed with respect to its property.
(c) Violation
of Law. Either party may terminate this Agreement immediately upon written notice, if the other party is operating in violation
of any law that governs this Agreement unless the parties are unable to negotiate an adjustment to the compensation or modification
to the Services in accordance with Section 3.3 to conform to the requirements of the law and address all legal obligations related
to the violation.
(d) Termination without Cause. Either party may terminate this Agreement without cause
upon giving thirty (30) days’ written notice to the other party.
(e) Effects
of Termination. Upon termination of this Agreement, as provided herein, neither party shall have any further obligations hereunder
except for (a) obligations accruing prior to the date of termination, and (b) obligations, promises, or covenants contained herein
that are expressly made to extend beyond the Term of this Agreement. The termination of the Agreement shall not relieve either
party of duties or obligations to promptly account for and pay to the other all amounts due under this Agreement through the date
of such termination; provided that in the event of a termination in accordance with section (c) above, the parties’ obligations
shall be limited by conformity to applicable law, i.e., neither party shall be entitled to performance of any obligation or payment
of any amount that would constitute a violation of law.
14.
CONFIDENTIALITY
The
parties understand and acknowledge that during the Term of this Agreement they may receive or have access to information of a proprietary
and confidential nature concerning the other party or the subject matter of this Agreement. “Confidential Information”
shall mean all information designated in writing by a party to be confidential and all information concerning a party that is not
otherwise publicly available, including but not limited to contents of any of the products, computer codes, software applications,
customer names, and pricing information. The parties shall use Confidential Information of the other solely for the purposes of
this Agreement and enforce appropriate restrictions on their authorized employees or agents who need to know such information to
carry out the terms of this Agreement. Upon the termination of this Agreement, each party will deliver to the other party any Confidential
Information of the other, whether delivered or created pursuant to this Agreement. No party shall retain any of the other party’s
Confidential Information, and upon written request, shall certify in writing to the return or destruction of such Confidential
Information. This covenant concerning Confidential Information shall survive the termination of this Agreement for a period of
two (2) years.
Page | 5
Services
Agreement
15.
ENTIRE AGREEMENT
This
Agreement sets forth the entire understanding and agreements of the parties hereto with respect to the subject matter hereof and
supersedes all other representations and understandings both written and oral. Additionally, the parties hereto agree to cancel,
and make null and void the Previous Contracts as of the Effective Date of this Agreement. This Agreement may be altered or modified
only in writing and signed by all parties hereto.
16.
NOTICES
All
notices, requests and other communications hereunder shall be in writing and shall be deemed to have been given only if mailed,
certified return receipt request, or if sent by a well-recognized private delivery service or if personally delivered to, or if
sent by fax or electronic mail with the original thereby sent by a means as specified below:
If to NHS: |
NHS Pharma Sales Inc. |
495
La Tortuga Dr., #120
Vista,
CA 92081 |
Attn: Charles Ronald Green, Jr. |
Fax: 909.666-5300 |
|
If to MESA: |
Mesa Pharmacy, Inc. |
18013 Sky Park Cir, Suite D |
Irvine, CA 92614 |
Attn: Edward Kurtz |
Fax: (949) 955-2925 |
All
notices, requests and other communications shall be deemed received on the date of acknowledgment or other evidence of actual receipt
in the case of certified mail, courier delivery or personal delivery, or in the case of fax delivery or electronic mail, upon the
date of fax receipt or the date of the electronic mail, provided the original is delivered within two (2) business days. Any party
hereto may designate different or additional parties for the receipt notice, pursuant to notice given in accordance with the foregoing.
IN
WITNESS WHEREOF, the parties have executed this Agreement in Vista, California, as of the Effective Date hereof.
|
NHS PHARMA SALES,
INC. |
|
|
MESA PHARMACY, INC. |
|
|
|
|
|
By: |
/s/ Ronald Green |
|
By: |
/s/ Edward Kurtz |
Print: |
Charles Ronald Green, Jr. |
|
Print: |
Edward Kurtz |
Address: |
495 La Tortuga Dr., #120, |
|
Address: |
18013 Sky Park Circle, Suite A |
|
Vista, CA 92081 |
|
|
Irvine, CA 92614 |
Page | 6
Praxsyn (CE) (USOTC:PXYN)
Gráfica de Acción Histórica
De Ene 2025 a Feb 2025
Praxsyn (CE) (USOTC:PXYN)
Gráfica de Acción Histórica
De Feb 2024 a Feb 2025